期刊文献+

阿戈美拉汀的多晶型研究 被引量:4

Study on the polymorphism of Agomelatine
原文传递
导出
摘要 目的研究阿戈美拉汀的多晶型特征。方法通过平衡溶解度测定、差示扫描量热分析(DSC)、红外光谱(IR)、粉末X射线衍射(PXRD)谱等鉴定阿戈美拉汀多的晶型,并考察其室温放置的稳定性。结果获得Ⅰ~Ⅳ型阿戈美拉汀。利用DSC或PXRD分析可区分4种晶型。结论不同晶型阿戈美拉汀的理化性质有明显差异。Ⅱ型阿戈美拉汀最稳定,Ⅰ、Ⅲ、Ⅳ型稳定性较差。 OBJECTIVE To find out the alteration of physicochemical properties on polymorphic crystalline forms of agomelatine.METHODS Characters of agomelatine polymorphs were detected by equilibrium solubility,DSC,IR and PXRD,while the stability was investigated at room temperature.RESULTS Agomelatine crystalline form Ⅰ-Ⅳ were obtained by polymorphous preparation.The four forms showed different DSC and PXRD patterns.CONCLUSION Different crystalline forms of agomelatine have different influences on physicochemical indexes.The stability of the polymorphic agomelatine is ⅡⅠ,Ⅲ and Ⅳ.
出处 《华西药学杂志》 CAS CSCD 北大核心 2012年第5期533-536,共4页 West China Journal of Pharmaceutical Sciences
关键词 阿戈美拉汀 多晶型 差示扫描量热法 红外光谱法 粉末X射线衍射法 稳定性 Agomelatine Polymorphism Differential scanning calorimetry Infrared spectrum X-ray powder diffraction Stability
  • 相关文献

参考文献9

  • 1胡茂荣,陈晋东,李乐华,国效峰,陆晓姿.阿戈美拉汀:一种新型抗抑郁药[J].中国新药与临床杂志,2009,28(2):81-85. 被引量:17
  • 2赵健,朱建强.阿戈美拉汀I型晶体的制备方法[P].CNl01704763A.2010-05-12. 被引量:1
  • 3Jc苏维,I冈萨雷斯布兰科,G托米诺,等.阿戈美拉汀的新合成方法、新晶型及其药物组合物[P].CNl321106C.2007-06-13. 被引量:1
  • 4G科克雷尔,J里诺尔,Jc苏维.阿戈美拉汀的新晶型Ⅲ、它的制备方法和包含它的药物组合物[P].CNl00450995C.2009-01-14. 被引量:1
  • 5G科克雷尔,J里诺尔,JC苏维.阿戈美拉汀的新晶型Ⅳ、它的制备方法和包含它的药物组合物[P].CNl00445264C.2008-12-24. 被引量:1
  • 6G科克雷尔,J利诺,JC苏维.阿戈美拉汀的新晶型V、它的制备方法和包含它的药物组合物[P].CNl00448843C.2009-01-07. 被引量:1
  • 7D马丁斯,G科克雷尔,J里诺尔,等.获得V晶形阿戈美拉汀的新方法[P].CNl01643432A.2010-02-10. 被引量:1
  • 8G科克雷尔,J里诺尔,L勒佩皮,等.阿戈美拉汀的新晶型Ⅵ、它的制备方法和包含它的药物组合物[P].CNl01429134A.2009-05-13. 被引量:1
  • 9JI2 Souvie, IG Blanco, G Thominot, et al. Process of the synthesis and crystalline form of agomelatine[ P]. US 2008/0004347 A1. 2008 - 01 - 03. 被引量:1

二级参考文献22

  • 1AUDINOT V, BONNAUD A, GRANDCOLAS L, et al. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors [J]. Biochem Pharmacol, 2008, 75(10): 2007-2019. 被引量:1
  • 2MILLAN M J, GOBERT A, LEJEUNE F, et al. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5- hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergie and adrenergic pathways [J]. Pharmacol Exp Ther, 2003, 306(3): 954-964. 被引量:1
  • 3PAPP M, GRUCA P, BOYER PA, et al. Effect of agomelatine in the chronic mild stress model of depression in the rat [J].Neuropsychopharmacology, 2003, 28(4): 694-703. 被引量:1
  • 4MILLAN MJ, BROCCO M, GOBERT A, et ol. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties : role of 5-HT2C receptor blockade[J]. Psychopharmacology (Berl), 2005, 177(4): 448-458. 被引量:1
  • 5BREMNER JD, NARAYAN M, ANDERSON ER, et al. Hippocampal volume reduction in major depression [J]. Am J Psychiatry, 2000, 157(1) : 115-118. 被引量:1
  • 6FUCHS E, FLUGGE G, CZEH B. Remodeling of neuronal networks by stress[J]. Front Biosci, 2006, 11 : 2746-2758. 被引量:1
  • 7DUMAN RS, MONTEGGIA LM. A neurotrophic model for stress related mood disorders [J]. Biol Psychiatry, 2006, 59 (12) : 1116-1127. 被引量:1
  • 8BANASR M, SOUMIER A, HERY M, et al. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis[J]. Biol Psychiatry, 2006, 59(11): 1087-1096. 被引量:1
  • 9REDMAN JR, GUARDIOLA-LEMAITRE B, BROWN M, et ol. Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms [J]. Psychopharmaeology (Bed), 1995, 118(4): 385-390. 被引量:1
  • 10MAILLIET F, AUDINOT V, MALPAUX B, et al. Molecular pharmacology of the ovine melatonin receptor: comparison with recombinant human MT1 and MT2 receptors [J]. Bioch Pharmacol, 2004, 67(4): 667-677. 被引量:1

共引文献16

同被引文献48

  • 1冒莉,郑启泰,吕扬.固体药物多晶型的研究进展[J].天然产物研究与开发,2005,17(3):371-375. 被引量:48
  • 2美国药典[S].37版.2752. 被引量:6
  • 3王海钠;庞华;董蓬.替莫唑胺多晶型的制备及其热稳定性[J]{H}医药导报,2012(11):1396-1400. 被引量:1
  • 4Linda Seton,Dikshitkumar Khamar,Ian J.Bradshaw. Solid State Forms of Theophylline Presenting a New Anhydrous Polymorph[J].{H}Crystal Growth & Design,2010,(09):3879-3886. 被引量:1
  • 5ArcadyL.Markel,Andrey F.Achkasov,Tatiana A.Alekhina a. Effects of the alpha-and gamma-polymorphs of glycine on the behavior of catalepsy prone rats[J].{H}Pharmacology Biochemistry and Behavior,2011,(02):234-240. 被引量:1
  • 6Ji-Hun An,Guang Jin Choi,Woo-Sik Kim. Polymorphic and kinetic investigation of adefovir dipivoxil during phase transformation[J].{H}International Journal of Pharmaceutics,2012,(1-2):185-193. 被引量:1
  • 7Pradeep Ghugare,Vaijanath Dongre,Pravin Karmuse. Solid state investigation and characterization of the polymorphic and pseudopolymorphic forms of indapamide[J].{H}Journal of Pharmaceutical and Biomedical Analysis,2010,(03):532-540. 被引量:1
  • 8Wen-Ting Cheng,Shan-Yang Lin,Mei-Jane Li. Raman microspectroscopic mapping orthermal system used to investigate milling-induced solid-state conversion of famotidine polymorphs[J].{H}Journal of Raman Spectroscopy,2007,(12):1595-1601. 被引量:1
  • 9于然;徐薇;龚宁波;吕扬.奥扎格雷的多晶型研究[A],2011140-144. 被引量:1
  • 10Yi Li,Pui Shan Chow,Reginald B,H.Tan. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry,X-ray powder diffraction and Raman spectroscopy[J].{H}International Journal of Pharmaceutics,2011,(1-2):110-118. 被引量:1

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部